University of Arizona Arthritis Center Represented at 2025 ACR Annual Convergence in Chicago
The University of Arizona Arthritis Center proudly recognizes the faculty, fellows, residents, and students who presented their research at the 2025 American College of Rheumatology (ACR) Annual Convergence in Chicago. ACR Convergence is the world’s leading rheumatology meeting, bringing together more than 10,000 clinicians, researchers, trainees, and health professionals from over 100 countries each year. The conference serves as the premier venue for presenting cutting-edge discoveries, advancing clinical practice, and fostering collaboration across the global rheumatology community.
Poster Presentations
Dr. Marci Macaraeg
“Distinct Endotypes of SURF associated with clinical phenotypes, inflammatory cytokines, and treatment responses”
Dr. C. Kent Kwoh
“Knee Symptom Phenotyping Incorporating Pain and Function across Different Levels of WOMAC Function in Two Cohorts: Data from the Multicenter Osteoarthritis Study (MOST) and the Osteoarthritis Initiative (OAI)”
Dr. Riyasha Daulat
“A Mystery in Metabolism: Unraveling an Atypical Presentation”
Greg Gilles, Graduate Student
“Multiplanar MRI Quantification of Effusion-Synovitis: Reliability and Potential Investigative Utility for Inflammation-Mediated Knee Conditions”
Dago Robles, MS, Doctoral Student
“Estimating the Association between Effusion-synovitis and Knee Pain in a Subset of Participants with Radiographic Knee Osteoarthritis: Data from the Osteoarthritis Initiative (OAI)”
Pawel Podsiadlo, Medical Student
“Trabecular Bone Texture is Associated with Structural and Pain Progressession in Later Stages of Knee Osteoarthritis: Longitudinal Data from the FNIH OAI Cohort”
Dr. Arathi Kulkarni and Dr. Keshavamurthy, Residents, with Dr. Wong, Fellow (second author)
“An Eye Opener”
Faissal Stipho, Medical Student
“Association of Semaglutide Prescription with Improved Joint Outcomes in Rheumatoid Arthritis Patients”
and
“COVID-19 Outcomes in Rheumatoid Arthritis Patients Prescribed Biologic vs. Conventional DMARDs: A Propensity-Matched Analysis”
Abstract Presentations
Dr. Ernest R. Vina
“Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes III”